WML Public Affairs has extensive experience and knowledge in healthcare policy in New Jersey and nationally.  In her roles in Government Relations and Public Affairs at Pfizer and as Chair of the NJ PhRMA State Task Force, Wendy has substantially impacted the healthcare policy landscape.  

​

Wendy is recognized for her work creating a coalition to advance legislation to limit patient out of pocket costs.  As a result of strategic guidance, the coalition successfully partnered with legislators to pass the only piece of state legislation nationally in over five years that caps out of pocket costs.  Wendy’s success in achieving compromise and policies that improved access to healthcare make WML a trusted partner to patient advocates and a valued source of information to policymakers.

​

Additionally, WML has a proven track record in improving the healthcare regulatory environment while defending the pharmaceutical industry against drug price affordability legislation.  WML has knowledge in numerous disease states and therapies, including vaccines, oncology, rare disease, cardiovascular, consumer products and much more.  With this extensive experience and having earned the respect of policymakers, advocates and partners, WML is well-positioned to represent your interests in the healthcare policy arena.

​